A new and efficient synthetic route for the anxiolytic agent CL285032.
@article{Ghidu2011ANA, title={A new and efficient synthetic route for the anxiolytic agent CL285032.}, author={Victor P. Ghidu and M. Ilies and T. Cullen and Robert Pollet and M. Abou-Gharbia}, journal={Bioorganic & medicinal chemistry letters}, year={2011}, volume={21 1}, pages={ 259-61 } }
CL285032 is an anxiolytic compound currently under investigation as a possible treatment for canine noise phobia associated anxiety. A robust scale-up and manufacturing process is essential for the development and marketability of the drug. The current synthetic route, although reliable, requires seven steps and has a low overall yield (18%), leaving opportunity for improvement. We are presenting an efficient alternative approach toward the synthesis of CL285032 and the results thereof.
Topics from this paper
5 Citations
LIN28/let-7/PD-L1 Pathway as a Target for Cancer Immunotherapy
- Chemistry, Medicine
- Cancer Immunology Research
- 2019
- 15
- PDF
References
SHOWING 1-4 OF 4 REFERENCES
Synthesis and anxiolytic activity of 6-(substituted-phenyl)-1,2,4-triazolo[4,3-b]pyridazines.
- Chemistry, Medicine
- Journal of medicinal chemistry
- 1981
- 59